Quality by Design‐Based Development of a Robust LC Method for Simultaneous Estimation of Process‐ and Degradation‐Related Impurities in Rifapentine Drug Product for the Treatment of Active and Latent Tuberculosis

Ähnliche Einträge

• Unique Liquid Chromatography Technique for Determining a New Selective PPARα Modulator Drug (Pemafibrate) in the Tablet Dosage Form, Robustness by Design Expert in the Light of Quality by Design
  von: Fei Han, et al.
  Veröffentlicht: (2025)
• Multiple Reaction Monitoring LC‐MS/MS Quantification of N‐Nitrosamine Drug Substance Related Impurities of Clonidine in Drug Substance and in Tablet Dosage Form
  von: Bhaskar Vallamkonda, et al.
  Veröffentlicht: (2025)
• Characterization and Analytical Method Validation for Potential Impurities of a Merchantability Drug Substance Fluoxetine HCl
  von: Rajani Reddy Janna Reddy, et al.
  Veröffentlicht: (2025)
• Forced Degradation Studies of Dobutamine and Isolation, Identification, and Characterization of Potential Degradation Impurity by Preparative HPLC, LC–MS/MS. Development and Validation of Stability Indicative UPLC Method
  von: Babu Reddy Goguladinne, et al.
  Veröffentlicht: (2025)
• Comprehensive Impurity and Degradation Profiling of Iptacopan Using a White–Green Stability‐Indicating HPLC Method Coupled With LC–MS/MS and In Silico Toxicity Evaluation
  von: Satyanarayana Reddy Jaggavarapu, et al.
  Veröffentlicht: (2026)